J2795 HCPCS code: Injection, ropivacaine hydrochloride, 1 mg
J2795 is the HCPCS Level II code for injection, ropivacaine hydrochloride, 1 mg. In 2024 Medicare paid an average of $0.05 per service for J2795 across 712,075 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 2400 per day on outpatient hospital claims. Medicare volume rose 9% from 2022 to 2024 (653,869 to 712,075 services). In 2024, about 616 clinicians billed Medicare for J2795 for 9,972 beneficiaries; Arizona, California, Michigan accounted for 65% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2001-01-01 |
| Last action effective | 2001-01-01 |
Who bills J2795 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 616 |
| Medicare beneficiaries | 9,972 |
| States with claims | 30 |
| Share of services in top 3 states (Arizona, California, Michigan) | 65% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2795, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 653,869 | 18,318 | $0.07 | $0.06 |
| 2023 | 729,340 | 17,396 | $0.07 | $0.06 |
| 2024 | 712,075 | 9,972 | $0.07 | $0.05 |
States with the most J2795 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Arizona | 218,450 | $0.05 |
| California | 160,511 | $0.05 |
| Michigan | 83,174 | $0.05 |
| Kansas | 66,233 | $0.05 |
| North Carolina | 48,243 | $0.05 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 2400 | Clinical: Data |
| practitioner claims | 200 | Prescribing Information |
What changed for J2795
- 2001-01-01: J2795 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2795?
J2795 is the HCPCS Level II code for injection, ropivacaine hydrochloride, 1 mg. Short descriptor: "Ropivacaine hcl injection".
How much does Medicare pay for J2795?
In 2024, the average Medicare payment was $0.05 per service (average allowed $0.07).
Does Medicare cover J2795?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2795 can be billed per day?
2400 on outpatient hospital claims; 200 on practitioner claims (NCCI medically unlikely edits).
Related J27 codes
- J2700 — Injection, oxacillin sodium, up to 250 mg
- J2704 — Injection, propofol, 10 mg
- J2710 — Injection, neostigmine methylsulfate, up to 0.5 mg
- J2711 — Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- J2720 — Injection, protamine sulfate, per 10 mg
- J2724 — Injection, protein c concentrate, intravenous, human, 10 iu
- J2725 — Injection, protirelin, per 250 mcg
- J2730 — Injection, pralidoxime chloride, up to 1 gm
- J2760 — Injection, phentolamine mesylate, up to 5 mg
- J2765 — Injection, metoclopramide hcl, up to 10 mg
- J2770 — Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777 — Injection, faricimab-svoa, 0.1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2795
- Watch J2795 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2795
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.